<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>One OTC Statin Out, One More To Go</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2005/01/17/One-OTC-Statin-Out-One-More-To-Go.aspx</link><description>I was somewhat relieved to read an FDA advisory committee rejected Merck's request to grant over-the-counter (OTC) status to Mevachor late Friday afternoon. Folks, it didn't look good early on, as Mevachor sailed through early voting last Thursday by</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>